Jansen Burkhard 4
4 · DermTech, Inc. · Filed Jun 26, 2020
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Jansen Burkhard
Chief Medical Officer
Transactions
- Award
Common Stock
2020-06-24+12,872→ 84,037 total - Award
Stock Option (right to buy)
2020-06-24+22,655→ 22,655 totalExercise: $14.88Exp: 2030-06-24→ Common Stock (22,655 underlying)
Footnotes (2)
- [F1]The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the restricted stock units shall vest on June 10, 2021 and (ii) the remaining thirty-six forty-eighths (36/48) shall vest in twelve (12) equal installments of three forty-eighths (3/48) on the tenth day of each third month following June 10, 2021 until the final vesting date on June 10, 2024.
- [F2]Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the shares of issuer common stock exercisable pursuant to this option shall vest on June 24, 2021 and (ii) the remaining thirty-six forty-eighths (36/48) shall vest in thirty-six (36) equal monthly installments of one forty-eighth (1/48) on the twenty-fourth day of each month following June 24, 2021 until the final vesting date on June 24, 2024.